ARBITER Arbiters: Analysts Say Both Sides Won
This article was originally published in RPM Report
Executive Summary
Excerpts from analysts notes following release of the ARBITER HALTS data, comparing Niaspan to Zetia in a study of atherosclerotic plaque.